Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Alemtuzumab in the treatment of multiple sclerosis: patient selection and special considerations.
Brain perfusion imaging with voxel-based analysis in secondary progressive multiple sclerosis patients with a moderate to severe stage of disease: a boon for the workforce.
Disability-Specific Atlases of Gray Matter Loss in Relapsing-Remitting Multiple Sclerosis.
Myelin oligodendrocyte glycoprotein induces incomplete tolerance of CD4(+) T cells specific for both a myelin and a neuronal self-antigen in mice.
Microtubule Dynamics in Neuronal Development, Plasticity, and Neurodegeneration.
Antibodies to myelin basic protein are associated with cognitive decline after stroke.
Back Cover: Eur. J. Immunol. 7'16.
Listeria rhombencephalitis mimicking a demyelinating event in an immunocompetent young patient.
Combination treatment of fingolimod with antidepressants in relapsing-remitting multiple sclerosis patients with depression: a multicentre, open-label study - REGAIN.
Vitamin D Intake and its Protective Role in Multiple Sclerosis: The Checkmate to Survivin?
Ciliary neurotrophic factor protects retinal ganglion cells from secondary cell death during acute autoimmune optic neuritis in rats.
Experimental autoimmune encephalomyelitis (EAE): lesion visualization on a 3 Tesla clinical whole-body system after intraperitoneal contrast injection.
Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis.
Selective and compartmentalized myelin expression of HspB5.
Lack of KIR4.1 autoantibodies in Japanese patients with MS and NMO.
"Venous congestion" as a cause of subcortical white matter T2 hypointensity on magnetic resonance images.
Multiple sclerosis: Dehydration might contribute to fatigue in MS.
Teaching Video NeuroImages: Primary writing tremor: Lessons from a patient with multiple sclerosis.
Understanding staff made my return to work possible.
Evaluation of species difference in peripheral lymphocyte reduction effect by CS-0777, a sphingosine 1-phosphate receptor modulator, based on a pharmacokinetic/pharmacodynamic model analysis.
Overexpression of Tau Rescues Nogo-66-Induced Neurite Outgrowth Inhibition In Vitro.
Risk of Premenopausal and Postmenopausal Breast Cancer among Multiple Sclerosis Patients.
Insights into the Pathogenesis and Treatment of Krabbe Disease.
Challenges in the acute management of profound hyponatremia presenting with severe symptoms.
Cytokine-induced release of ceramide-enriched exosomes as a mediator of cell death signaling in an oligodendroglioma cell line.
Pages
« first
‹ previous
…
771
772
773
774
775
776
777
778
779
…
next ›
last »